The prevalence and clinical characteristics of punding in Parkinson's disease

Movement Disorders

Volumn 26, Issue 4, 2011, Pages 578-586

  Spencer, Ashley H ^a   Rickards, Hugh ^a   Fasano, Alfonso ^b   Cavanna, Andrea E ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b IRCCS NEUROMED   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Behavioral disorders; Dopamine; Parkinson's disease; Punding; Stereotyped movements

Indexed keywords

AMANTADINE; ATYPICAL ANTIPSYCHOTIC AGENT; BROMOCRIPTINE; CABERGOLINE; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINESTERASE INHIBITOR; DONEPEZIL; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; QUETIAPINE; ROPINIROLE; ROTIGOTINE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; THREO 3,4 DIHYDROXYPHENYLSERINE;

BEHAVIOR DISORDER; BRAIN DEPTH STIMULATION; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSKINESIA; GENDER; HUMAN; IMPULSE CONTROL DISORDER; ONSET AGE; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; PUNDING; REVIEW; SYSTEMATIC REVIEW;

ADULT; AGED; DATABASES, BIBLIOGRAPHIC; DOPAMINE AGENTS; FEMALE; HUMANS; IMPULSE CONTROL DISORDERS; MALE; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; STEREOTYPIC MOVEMENT DISORDER;

EID: 79955003367     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23508     Document Type: Review

References (71)

1. Ferrara JM, Stacy M. Impulse control disorders in Parkinson's disease. CNS Spectr 2008; 13: 690-698.
2. Voon V, Fox SH. Medication-related impulse control and repetitive behaviours in Parkinson disease. Arch Neurol 2007; 64: 1089-1096.
3. O'Sullivan, Evans AH, Lees AJ. Punding in Parkinson's disease. Pract Neurol 2007; 7: 397-399.
4. Miwa H. Stereotyped behaviours or punding in Parkinson's disease. J Neurol 2007; 254: 61-67.
5. Rylander G. Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs. Psychiatr Neurol Neurochir 1972; 75: 203-212.
6. Rylander G. Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs. Psychiatr Neurol Neurochir 1972; 75: 203-212.
7. Brady KT, Lydiard RB, Malcolm R, Ballenger JC. Cocaine-induced psychosis. J Clin Psychiatr 1991; 52: 509-512.
8. Fasano A, Barra A, Nicosia P, Rinaldi F, Bria P, Bentivoglio AR. Tononi F. Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding. Drug Alcohol Depend 2008; 96: 178-182.
9. Cornelius JR, Tippmann-Peikert M, Slocumb NL, Frerichs CF, Silber MH. Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep 2010; 33: 81-87.
10. Evans AH, Stegeman JR. Punding in patients on dopamine agonists for restless leg syndrome. Mov Disord 2008; 24: 140-141.
11. Andén NE, Carlsson A, Kerstell J, et al. Oral L-dopa treatment of parkinsonism. Acta Med Scand 1970; 187: 247-255.
12. Friedman JH. Punding on levodopa. Biol Psychiatry 1994; 36: 350-351.
13. Kulisevsky J, Pagonabarraga J, Martinez-Corral M. Changes in artistic style and behaviour in Parkinson's disease: dopamine and creativity. J Neurol 2009; 256: 816-819.
14. Wingo TS, Evatt M, Scott B, Freeman A, Stacy M. Impulse control disorders arising in 3 patients treated with rotigotine. Clin Neuropharmacol 2009; 32: 59-62.
15. Miwa H, Kondo T. Alteration of eating behaviours in patients with Parkinson's disease: possibly overlooked? Neurocase 2008; 14: 480-484.
16. Kimber TE, Thompson PD, Kiley MA. Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson's disease. J Clin Neurosci 2008: 15; 205-208.
17. Bonvin C, Horvath J, Christe B, Landis T, Burkhard PR. Compulsive singing: another aspect of punding in Parkinson's disease. Ann Neurol 2007; 62: 525-528.
18. McKeon A, Josephs KA, Klos KJ, et al. Unusual compulsive behaviors primarily related to dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord 2007; 13: 516-519.
19. Kummer A, Maia DP, Salgado JV, Cardoso FE, Teixeira AL. Dopamine dysregulation syndrome in Parkinson's disease: case report. Arq Neuropsiquiatr 2006; 64: 1019-1022.
20. Shapiro MA, Chang YL, Munson SK, Okun MS, Fernandez HH. Hypersexuality and paraphilia induced by selegiline in Parkinson's disease: report of 2 cases. Parkinsonism Relat Disord 2006; 12: 439-435.
21. Fasano A, Elia AE, Soleti F, Guidubaldi A, Bentivoglio AR. Punding and computer addiction in Parkinson's disease. Mov Disord 2006; 21: 1217-1218.
22. Nirenberg MJ, Waters C. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord 2006; 21: 524-529.
23. Miwa H, Kondo T. Increased writing activity in Parkinson's disease: a punding-like behavior? Parkinsonism Relat Disord 2005; 11: 323-325.
24. Kumar S. Punding in Parkinson's disease related to high-dose levodopa therapy. Neurol India 2005; 53: 362.
25. Miwa H, Morita S, Nakanishi I, Kondo T. Stereotyped behaviors or punding after quetiapine administration in Parkinson's disease. Parkinsonism Relat Disord 2004; 10: 177-180.
26. Kurlan R. Disabling repetitive behaviors in Parkinson's disease. Mov Disord 2004; 19: 433-437.
27. Serrano-Duenas M. Chronic dopaminergic drug addiction and pathologic gambling in patients with Parkinson's disease: presentation of four cases. Ger J Psychiatr 2002; 5: 62-67.
28. Meseguer Gancedo E, Garcia Ruiz P. Punding in Parkinson's disease. Neurologia 2002; 17: 228.
29. Fernandez HH, Friedman JH. Punding on L-dopa. Mov Disord 1999; 14: 836-838.
30. Evans AH, Katzenschlager R, Paviour D, et al. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 2004; 19: 397-405.
31. Voon V, Hassan K, Zurowski M, et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 2006; 67: 1254-1257.
32. Miyasaki JM, Al Hassan K, Lang AE, Voon V. Punding prevalence in Parkinson's disease. Mov Disord 2007; 22: 1179-1181.
33. Lee JY, Lee EK, Park SS, Lim JY, Kim HJ, Kim JS, Jeon BS. Association of DRD3 and GRIN2B with impulse control and related behaviours in Parkinson's disease. Mov Disord 2009; 24: 1803-1810.
34. Weintraub D, Hoops S, Shea JA, et al. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord 2009; 24: 1461-1467.
35. Silveira-Moriyama L, Evans AH, Katzenschlager R, Lees AJ. Punding and dyskinesias. Mov Disord 2006; 21: 2214-2217.
36. Lawrence AJ, Blackwell AD, Barker RA, Spagnolo F, Clark L, Aitken MR, Sahakian BJ. Predictors of punding in Parkinson's disease: results from a questionnaire survey. Mov Disord 2007; 22: 2339-4235.
37. Barratt ES. Impulsiveness and aggression. In: Monahan J, Steadman HE, editors. Violence and mental disorder developments in risk assessment. Chicago: University of Chicago Press; 1994. p 61-79.
38. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson's disease questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing 1997; 26: 353-357.
39. Weiss HD, Hirsch E, Swerigen L, et al. Impulse control disorders in Parkinson's disease patients followed in a community-based neurology practice. Mov Disord 2008; 23: S281.
40. Evans AH, Strafella AP, Weintraub D, Stacy M. Impulsive and compulsive behaviors in Parkinson's disease. Mov Disord 2009; 24: 1561-1570.
41. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition, text revision. Washington, DC: American Psychiatric Association; 1994.
42. Cabrini S, Baratti M, Bonfà F, Cabri G, Uber E, Avanzi M. Preliminary evaluation of the DDS-PC inventory: a new tool to assess impulsive-compulsive behaviours associated to dopamine replacement therapy in Parkinson's disease. Neurol Sci (in press).
43. Wolters ECh, van der Werf YD, van den Heuvel OA. Parkinson's disease-related disorders in the impulsive-compulsive spectrum. J Neurol 2008; 255: 48-55.
44. Black KJ, Friedman JH. Repetitive and impulsive behaviors in treated Parkinson disease. Neurology 2006; 67: 1118-1119.
45. Fasano A, Petrovic I. Insights into pathophysiology of punding reveal possible treatment strategies. Mol Psychiatr 2009; 15: 560-573.
46. Menza MA, Golbe LI, Cody RA, Forman NE. Dopamine-related personality traits in Parkinson's disease. Neurology 1993; 43: 505-508.
47. Kaasinen V, Aalto S, Nagren K, Rinne JO. Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease. Curr Psychiatry Rep 2000; 2: 421-426.
48. Menza MA. The personality associated with Parkinson's disease. Curr Psychiatry Rep 2000; 2: 421-426.
49. Menza MA, Formal NE, Goldstein HS, Golbe LI. Parkinson's disease, personality and dopamine. J Neuropsychiatry Clin Neurosci 1990; 2: 282-287.
50. Tomer R, Aharon-Peretz J. Novelty seeking and harm avoidance in Parkinson's disease: effects of asymmetric dopamine deficiency. J Neurol Neurosurg Psychiatry 2004; 75: 972-975.
51. Weintraub D. Dopamine and impulse control disorders in Parkinson's disease. Ann Neurol 2008; 64: S93-S100.
52. Kissoon N, Tuite P, Fernandez H, Thomas C. Parkinson's Disease, First ed. New York: Springer Publishing Company; 2009.
53. Schrag A, Schott JM. Epidemiological, clinical and genetic characteristics of early-onset parkinsonism. Lancet Neurol 2006; 5: 355-363.
54. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N Eng J Med 1988; 318: 816-880.
55. Swainson R, Rogers RD, Sahakian BJ, Summers BA, Polkey CE, Robbins TW. Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologia 2000; 38: 596-612.
56. Cools R. Dopaminergic modulation of cognitive function: implications for l-dopa treatment in Parkinson's disease. Neurosci Biobehav Rev 2006; 30: 1-23.
57. Radad K, Gille G, Rausch WD. Short review on dopamine agonists: insight into clinical and research studies relevant to Parkinson's disease. Pharmacol Rep 2005; 57: 701-712.
58. Watts RL. The role of dopamine agonists in early Parkinson's disease. Neurology 1997; 49: S34-S48.
59. Ali-Cherif A, Royere ML, Gosset A, Poncet M, Salamon G, Khalil R. Behavior and mental activity disorders after carbon monoxide poisoning. Rev Neurol 1984; 140: 401-405.
60. Laplane D, Baulac M, Widlocher D, Dubois B. Pure psychic akinesia with bilateral lesions of basal ganglia. J Neurol Neurosurg Psychiatry 1984; 47: 377-385.
61. Laplane D, Levasseur M, Pillon B, et al. Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions: a neuropsychological, magnetic resonance imaging and positron tomography study. Brain 1989; 112: 699-725.
62. Miwa H, Miwa T, Imai H, Mizuno Y. Obsessive-compulsive-like behavioural changes in pure akinesia. Parkinsonism Relat Disord 2001; 7: 315-317.
63. Arnt J, Hyttel J, Perregaard J. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats. Eur J Pharmacol 1987; 133: 137-145.
64. Canales JJ, Graybiel AM. A measure of striatal function predicts motor stereotypy. Nat Neurosci 2000; 3: 377-383.
65. Capper-Loup C, Canales JJ, Kadaba N, Graybiel AM. Concurrent activation of dopamine D1 and D2 receptors is required to evoke neural and behavioural phenotypes of cocaine sensitization. J Neurosci 2002; 22: 6218-6227.
66. Gerdeman GL, Partridge JG, Lupica CR, Lovinger DM. It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci 2003; 26: 184-192.
67. LaHoste GJ, Yu J, Marshall JF. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. Proc Natl Acad Sci USA 1993; 90: 7451-7455.
68. Evans AH, Pavese N, Lawrence AD, et al. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 2006; 59: 852-858.
69. Lim S-Y, O'Sullivan SS, Kotschet K, et al. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease. J Clin Neurosci 2009; 16: 1148-1152.
70. Voon V. Repetition, repetition, and repetition: compulsive and punding behaviors in Parkinson's disease. Mov Disord 2004; 19: 367-370.
71. Fasano A, Pettorruso, M, Ricciardi L, Conte GL, Bentivoglio AR. Punding in Parkinson's disease: the impact of patient's awareness on diagnosis. Mov Disord 2010; 25: 1297-1299.